633
Views
67
CrossRef citations to date
0
Altmetric
Research Article

Neuroanatomical markers of genetic liability to psychosis and first episode psychosis: A voxelwise meta-analytical comparison

, , , &
Pages 219-228 | Received 22 Apr 2011, Accepted 27 Sep 2011, Published online: 27 Jan 2012

References

  • Allen P, Laroi F, McGuire PK, Aleman A. 2008. The hallucinating brain: a review of structural and functional neuroimaging stud-ies of hallucinations. Neurosci Biobehav Rev 32(1): 175–191.
  • Berge D, Carmona S, et al. (2010). Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects. Acta Psychiatr Scand.
  • Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. 2007. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophr Res 93(1–3):1–12.
  • Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE. 1990. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147(11):1457–1462.
  • Boksman K, Theberge J, Williamson P, Drost DJ, Malla A, Densmore M, et al. 2005. A 4.0-T fMRI study of brain connectivity during word fluency in first-episode schizophrenia. Schizophr Res 75(2–3):247–263.
  • Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, et al. 2011. Neuroanatomical abnormalities in schizophrenia: A multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res.
  • Borgwardt SJ, McGuire P, Fusar-Poli P, Radue EW, Riecher-Rossler A. 2008. Anterior cingulate pathology in the prodromal stage of schizophrenia. Neuroimage 39(2):553–554.
  • Borgwardt SJ, Smieskova R, Fusar-Poli P, Bendfeldt K, Riecher-Rossler A. 2009. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?. Psychol Med 39(11):1781–1782.
  • Borgwardt SJ, Picchioni MM, et al. (2009). Regional Gray Matter Volume in Monozygotic Twins Concordant and Discordant for Schizophrenia. Biol Psychiatry.
  • Broome MR, Matthiasson P, Fusar-Poli P, Woolley J, Johns L, Tabraham P, et al. 2009. Neural correlates of executive function and working memory in the ‘at-risk mental state’. Br J Psychiatry 194((1)):25–33.
  • Callicott JH, Egan MF, Mattay VS, Bertolino A, Bone AD, Verchinksi B, et al. 2003. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160(4):709–719.
  • Chang CJ, Chen WJ, Liu SK, Cheng JJ, Yang WC, Chang HJ, et al. 2002. Morbidity risk of psychiatric disorders among the first degree relatives of schizophrenia patients in Taiwan. Schizophr Bull 28(3):379–392.
  • Chua SE, Cheung C, et al. (2007). Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res 89(1–3):12–21.
  • Corcoran CM, First MB, Cornblatt B. 2010. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res 120(1-3):16–22.
  • Crossley NA, Mechelli A, Fusar-Poli P, Broome MR, Matthiasson P, Johns LC, et al. 2009. Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp 30(12):4129–4137.
  • Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634.
  • Fornito A, Yucel M, Dean B, Wood SJ, Pantelis C. 2008. Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology. Schizophr Bull.
  • Fusar-Poli P, Allen P, McGuire P. 2008. Neuroimaging studies of the early stages of psychosis: a critical review. Eur Psychiatry 23(4):237–244.
  • Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton M, Barale F, et al. 2011a. Predicting psychosis: a meta-analysis of evidence. Arch Gen Psychiatry: in press.
  • Fusar-Poli P, Borgwardt S, Crescini A, D’Este G, Kempton M, Lawrie S, et al. 2010a. Neuroanatomy of Vulnerability to Psychosis: A Voxel-Based Meta-Analysis. Neurosci Biobehav Rev 35(5):1175–1185.
  • Fusar-Poli P, Broome M, Woolley J, Johns L, Tabraham P, Bramon E, et al. 2010b. Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study. Journal of Psychiatric Research in press.
  • Fusar-Poli P, Broome MR, Matthiasson P, Williams SC, Brammer M, McGuire PK. 2007a. Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. Eur Neuropsychopharmacol 17(6-7):492–500.
  • Fusar-Poli P, Broome MR. 2006. Conceptual issues in psychiatric neuroimaging. Curr Opin Psychiatry 19(6):608–612.
  • Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, et al. 2009. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry.
  • Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, et al. 2010c. Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry 67(7):683–691.
  • Fusar-Poli P, Perez J, Broome M, Borgwardt S, Placentino A, Caverzasi E, et al. 2007b. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 31(4):465–484.
  • Fusar-Poli P, Stone J, Broome M, Valli I, Mechelli A, McLean M, et al. 2011b. Thalamic glutamate levels predicts cortical response during executive functioning in subjects at high risk for psychosis. Arch Gen Psychiatry: May 2, Epub.
  • Gottesman I, Gould T. 2003. The endophenotype concept in psychiatry: etymology and strategi intentions. American Journal of Psychiatry 160(4):636–645.
  • Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. 2011. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68(2):128–137.
  • Honea RA, Meyer-Lindenberg A, et al. (2008). Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry 63(5):465–474.
  • Hulshoff Pol HE, Schnack HG, et al. (2006). Gray and white matter density changes in monozygotic and same-sex dizygotic twins discordant for schizophrenia using voxel-based morphometry. Neuroimage 31(2):482–488.
  • Jardri R, Pouchet A, Pins D, Thomas P. 2011. Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. Am J Psychiatry 168(1):73–81.
  • Jayakumar PN, Venkatasubramanian G, et al. (2005). Optimized voxel-based morphometry of gray matter volume in first- episode, antipsychotic-naive schizophrenia. Prog Neuropsy- chopharmacol Biol Psychiatry 29(4):587–591.
  • Job DE, Whalley HC, et al. (2003). Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr Res 64(1):1–13.
  • Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, et al. 2004. Clozapine but not haloperidol Re- establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 29(1):171–178.
  • Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL. 2009. Modulation of Limbic Circuitry Predicts Treatment Response to Antipsychotic Medication: A Functional Imaging Study in Schizophrenia. Neuropsychopharmacology.
  • Lawrie SM, McIntosh AM, Hall J, Owens DG, Johnstone EC. 2008. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr Bull 34(2):330–340.
  • Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, et al. 2009. Gray Matter in First-Episode Schizophrenia Before and After Antipsychotic Drug Treatment. Anatomical Likelihood Estimation Meta-analyses With Sample Size Weighting. Schizophr Bull 37(1):199–211.
  • Lipsey M, Wilson D. (2000). Practical Meta-analysis. Thousand Oaks, CA, Sage Publications.
  • Lui S, Deng W, et al. (2009). Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry 166(2): 196–205.
  • Lui S, Deng W, et al. (2009). Neuroanatomical differences between familial and sporadic schizophrenia and their parents: an optimized voxel-based morphometry study. Psychiatry Res 171(2):71–81.
  • Mane A, Falcon C, et al. (2009). Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. Schizophr Res 114(1–3): 136 143.
  • Marcelis M, Suckling J, et al. (2003). Searching for a structural endophenotype in psychosis using computational morphometry. Psychiatry Res 122(3):153–167.
  • McGuire P, Howes OD, Stone J, Fusar-Poli P. 2008. Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci 29(2):91–98.
  • McIntosh AM, Baig BJ, Hall J, Job D, Whalley HC, Lymer GK, et al. 2007. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biol Psychiatry 61(10): 1127–1134.
  • McIntosh AM, Job DE, et al. (2004). Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. Biol Psychiatry 56(8):544–552.
  • Mechelli A, Price C, Friston J, Ashburner J. 2005. Voxel-Based Morphometry of the Human Brain: Methods and Applications. Current Medical Imaging Reviews 1(1):0–9.
  • Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, and Stroup DF. 2000. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group. Br J Surg 87(11):1448–1454.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339: b2535.
  • Nelson B, Yung AR. 2010. Should a risk syndrome for first episode psychosis be included in the DSM-V? Curr Opin Psychiatry: Nov 30 Epub.
  • Orwin R. 1983. A fail-safe N for effect size in meta-analysis. J Edu Stat 8(2):157–159.
  • Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. 2003. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361(9354):281–288.
  • Prasad KM, Shirts BH, et al. (2007). Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol Psychiatry 12(1):105–113, 101.
  • Radua J, Mataix-Cols D. 2009. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry 195(5):393–402.
  • Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D. 2010. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 67(7):701–711.
  • Riecher-Rossler A, Pflueger MO, Aston J, Borgwardt SJ, Brewer WJ, Gschwandtner U, et al. 2009. Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry 66(11):1023–1030.
  • Ruhrmann S, Schultze-Lutter F, Bechdolf A, Klosterkotter J. 2010a. Intervention in at-risk states for developing psychosis. Eur Arch Psychiatry Clin Neurosci 260 Suppl 2:S90–94.
  • Ruhrmann S, Schultze-Lutter F, Klosterkotter J. 2010b. Probably at-risk, but certainly ill advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 120(1–3): 23–37.
  • Salgado-Pineda, P., I. Baeza, et al. (2003). Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 19(2 Pt 1):365–375.
  • Schmahmann JD, Weilburg JB, Sherman JC. 2007. The neuropsychiatry of the cerebellum insights from the clinic. Cerebellum 6(3):254–267.
  • Smieskova R, Allen P, Simon A, Aston J, Bendfeldt K, Drewe J, et al. 2011. Different duration of at-risk mental state associated with neurofunctional abnormalities – A multimodal imaging study. Hum Brain Mapp: in press.
  • Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. 2009. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia? a systematic review. Curr Pharm Des 15(22): 2535–2549.
  • Smieskova R, Fusar-Poli Allen P, Bendfeldt K, Stieglitz R, Drewe J, et al. 2010. Neuroimaging predictors of transition to psychosis – A systematic review and meta-analysis. Neuroscience and Biobehavioural Reviews 34(8):1207–1222.
  • Snitz BE, Macdonald A, , 3rdCohen JD, Cho RY, Becker T, Carter CS. 2005. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 162(12):2322–2329.
  • Stip E, Mancini-Marie A, Letourneau G, Fahim C, Mensour B, Crivello F, et al. 2009. Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study. Int Clin Psychopharmacol 24(1):34–41.
  • Sun J, Maller JJ, Guo L, Fitzgerald PB. 2009. Superior temporal gyrus volume change in schizophrenia: a review on region of interest volumetric studies. Brain Res Rev 61(1):14–32.
  • Takahashi T, Wood SJ, Yung AR, Soulsby B, McGorry PD, Suzuki M, et al. 2009. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry 66(4):366–376.
  • Tan HY, Choo WC, Fones CS, Chee MW. 2005. fMRI study of maintenance and manipulation processes within working memory in first-episode schizophrenia. Am J Psychiatry 162(10): 1849–1858.
  • Todtenkopf MS, Vincent SL, Benes FM. 2005. A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res 73(1):79–89.
  • Tsuang MT, Stone WS, Faraone SV. 2002. Understanding predisposition to schizophrenia: toward intervention and prevention. Can J Psychiatry 47(6):518–526.
  • Whalley HC, Simonotto E, Moorhead W, McIntosh A, Marshall I, Ebmeier KP, et al. 2006. Functional Imaging as a Predictor of Schizophrenia. Biol Psychiatry 60(5): 454–462.
  • Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, et al. 2007. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophr Bull 33(3):673–681.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.